IPO registrations (S-1, F-1) · Registrants
NEPHROS INC
- SEC CIK
- 1196298 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-06-04, last 2019-07-18; 13 initial registrations, 19 amendments
- Outcome
- Final prospectus filed 2004-09-21; declared effective 2008-05-05; withdrawal requested 2009-10-30
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 380 LACKAWANNA PLACE, South Orange, NJ 07079
- EIN
- 13-3971809
- Ticker
- NEPH (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- NEPHROS INC on the corporate pages
On this site
- Business registration: Nephros Inc. Fuzzy (name and state)
- Business registration: NEPHROS, INC Fuzzy (name and state)
- Form 5500 plan sponsor: NEPHROS INC EXACT (EIN (EXACT))
- Federal award recipient: NEPHROS, INC. Fuzzy (name and state)
- Form D issuer: NEPHROS INC EXACT (CIK (EXACT))
- SEC filer: NEPHROS INC EXACT (CIK (EXACT))
Filings 67
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-06-04 | S-1 | S-1 (registration) | NEPHROS INC | 0001193125-04-098762 ↗ |
| 2004-07-20 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001193125-04-121110 ↗ |
| 2004-08-26 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001193125-04-147376 ↗ |
| 2004-09-10 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001193125-04-155033 ↗ |
| 2004-09-16 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001193125-04-157650 ↗ |
| 2004-09-20 | S-1MEF | S-1MEF (added securities) | NEPHROS INC | 0001193125-04-158977 ↗ |
| 2004-09-21 | 424B1 | 424B1 (final prospectus) | NEPHROS INC | 0001193125-04-159176 ↗ |
| 2008-05-05 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-08-001443 ↗ |
| 2009-08-25 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-09-002378 ↗ |
| 2009-10-02 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-09-051262 ↗ |
| 2009-10-30 | RW | RW (withdrawal request) | NEPHROS INC | 0001144204-09-055655 ↗ |
| 2009-10-30 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-09-055673 ↗ |
| 2009-12-16 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-09-064742 ↗ |
| 2009-12-24 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-09-066368 ↗ |
| 2010-01-21 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-002984 ↗ |
| 2010-02-10 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-006411 ↗ |
| 2010-02-12 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-007073 ↗ |
| 2010-02-12 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-007219 ↗ |
| 2010-02-16 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-10-000516 ↗ |
| 2010-03-10 | RW | RW (withdrawal request) | NEPHROS INC | 0001144204-10-012515 ↗ |
| 2010-05-21 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-10-029670 ↗ |
| 2010-06-18 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-034225 ↗ |
| 2010-10-01 | RW | RW (withdrawal request) | NEPHROS INC | 0001144204-10-052014 ↗ |
| 2010-10-01 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-10-052070 ↗ |
| 2010-11-08 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-058306 ↗ |
| 2010-12-22 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-10-067705 ↗ |
| 2011-01-24 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-11-003738 ↗ |
| 2011-01-27 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-11-004467 ↗ |
| 2011-01-31 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-11-000308 ↗ |
| 2011-03-18 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-11-000714 ↗ |
| 2011-10-18 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-11-002967 ↗ |
| 2012-04-05 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-12-000949 ↗ |
| 2013-03-04 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-13-012724 ↗ |
| 2013-04-08 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-13-020606 ↗ |
| 2013-04-17 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-13-001028 ↗ |
| 2013-04-17 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-13-001049 ↗ |
| 2014-01-07 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-14-000958 ↗ |
| 2014-02-04 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-14-005632 ↗ |
| 2014-02-12 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-14-000423 ↗ |
| 2014-04-14 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-14-000982 ↗ |
| 2014-10-20 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-14-061978 ↗ |
| 2014-10-31 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001144204-14-064429 ↗ |
| 2014-11-04 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-14-003240 ↗ |
| 2015-06-23 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-15-038669 ↗ |
| 2015-06-29 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-15-001757 ↗ |
| 2015-07-06 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-15-001836 ↗ |
| 2015-08-13 | S-1 | S-1 (registration) | NEPHROS INC | 0001144204-15-049019 ↗ |
| 2015-09-04 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-15-002455 ↗ |
| 2015-12-17 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-15-003299 ↗ |
| 2016-05-10 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-16-004596 ↗ |
| 2016-05-10 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-16-004609 ↗ |
| 2017-04-14 | S-1 | S-1 (registration) | NEPHROS INC | 0001493152-17-003881 ↗ |
| 2017-04-20 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-17-000910 ↗ |
| 2017-04-20 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-17-000911 ↗ |
| 2017-04-26 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-17-000976 ↗ |
| 2018-04-03 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-18-000737 ↗ |
| 2018-04-03 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-18-000738 ↗ |
| 2018-04-03 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-18-000739 ↗ |
| 2018-05-22 | S-1 | S-1 (registration) | NEPHROS INC | 0001493152-18-007669 ↗ |
| 2018-06-20 | S-1/A | S-1/A (amendment) | NEPHROS INC | 0001493152-18-009010 ↗ |
| 2018-06-22 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-18-001602 ↗ |
| 2019-05-13 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-19-001097 ↗ |
| 2019-07-18 | S-1 | S-1 (registration) | NEPHROS INC | 0001493152-19-010796 ↗ |
| 2019-07-31 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-19-001769 ↗ |
| 2019-10-15 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-19-002307 ↗ |
| 2019-10-15 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-19-002309 ↗ |
| 2019-12-06 | EFFECT | EFFECT (declared effective) | NEPHROS INC | 9999999995-19-002752 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Prashker Bruce | Officer | Interim CFO | 1 | 2006 | |
| CENTELLA LAWRENCE J | Director | 13 | 2006–2015 | ||
| DAVIS HOWARD ALAN | Director | 2 | 2006–2007 | ||
| DRAPKIN DONALD G | Director | 2 | 2006–2007 | ||
| FOX WILLIAM J | Director; Director,Officer | Executive Chairman | 2 | 2006 | |
| ROSE ERIC A MD | Director | 3 | 2006–2009 | ||
| SALICK BERNARD | Director | 2 | 2006–2007 | ||
| ZIEBOLD W TOWNSEND JR | Director | 2 | 2006–2007 | ||
| Lerner Mark W | Officer | Chief Financial Officer | 2 | 2006 | |
| Slotkin Judy S | Director | 3 | 2006–2007 | ||
| Amron Arthur H | Director | 29 | 2007–2026 | ||
| DAVIDSON CHARLES E | Director,TenPercentOwner; TenPercentOwner | 16 | 2007–2026 | ||
| JACOBS JOSEPH | Director,TenPercentOwner; TenPercentOwner | 16 | 2007–2026 | ||
| Lambda Investors LLC | Director,TenPercentOwner; TenPercentOwner | 10 | 2007–2016 | ||
| Mieyal Paul A | Director; Director,Officer | Acting Chief Executive Officer | 16 | 2007–2019 | |
| WEXFORD CAPITAL LLC | Director,TenPercentOwner; TenPercentOwner | 16 | 2007–2026 | ||
| Enso Capital Management LLC | TenPercentOwner | 12 | 2007–2009 | ||
| Enso Capital Management Ltd | TenPercentOwner | 12 | 2007–2009 | ||
| Enso Global Equities Master Partnership LP | TenPercentOwner | 10 | 2007–2009 | ||
| Fink Joshua A | TenPercentOwner | 12 | 2007–2009 | ||
| Golden Howard | TenPercentOwner | 8 | 2007–2011 | ||
| Southpaw Asset Management LP | TenPercentOwner | 8 | 2007–2011 | ||
| Southpaw Credit Opportunity Master Fund, L.P. | TenPercentOwner | 5 | 2007–2011 | ||
| Southpaw Holdings LLC | TenPercentOwner | 8 | 2007–2011 | ||
| Wyman Kevin | TenPercentOwner | 8 | 2007–2011 | ||
| 3V Capital Management LLC | TenPercentOwner | 4 | 2007–2008 | ||
| Stagg Scott A | TenPercentOwner | 3 | 2007–2008 | ||
| BARTA NORMAN J | Director,Officer | Pres., CEO and Chairman | 1 | 2007 | |
| Scibetta James S | Director | 9 | 2007–2014 | ||
| Elgin Ernest III | Director,Officer; Officer | President and CEO | 4 | 2008–2010 | |
| ENSO GLOBAL EQUITIES LEVERED MASTER PARTNERSHIP, LP | Director; TenPercentOwner | 5 | 2008 | ||
| Kochanski Gerald John SR | Officer | CFO, Sec. and Treasurer; CFO, Secretary and Treasurer; Chief Financial Officer | 7 | 2009–2013 | |
| Wexford GP LLC | Director,TenPercentOwner; TenPercentOwner | 14 | 2011–2026 | ||
| Houghton John C. | Director,Officer | President and CEO; President, CEO and Acting CFO | 6 | 2012–2014 | |
| Evans Daron | Director; Director,Officer; Officer | CEO of Specialty Renal Product; CEO Specialty Renal Products; President and CEO | 37 | 2013–2021 | |
| ROSENBERG MATTHEW | Director | 6 | 2014–2015 | ||
| PERSEN MALCOLM C | Director | 11 | 2015–2021 | ||
| Pinto Moshe | Director | 9 | 2015–2018 | ||
| Astor Andrew | Director,Officer; Officer | CFO/COO; Chief Financial Officer; COO/CFO; President & CEO; President, CEO & CFO; President/CEO/CFO | 29 | 2017–2022 | |
| Spandow Oliver J. | Director | 14 | 2018–2025 | ||
| Lask Alisa | Director | 11 | 2019–2025 | ||
| Gwydir Tom | Director | 7 | 2019–2023 | ||
| D'Agostino Daniel S. | Officer | Chief Financial Officer | 1 | 2020 | |
| Lobo Wesley S. | Officer | Chief Commercial Officer; Chief Marketing Officer | 5 | 2021–2022 | |
| Harris Joseph Michael | Director | 6 | 2022–2025 | ||
| Banks Robert R. Jr. | Director,Officer; Officer | President and CEO | 5 | 2023–2026 | |
| Krandel Judy | Officer | Chief Financial Officer | 5 | 2023–2026 | |
| Nettis Lisa Marie | Director | 3 | 2025 | ||
| Amron Holdings LLC | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-07-14 | NEPHROS INC | Other Health Care | $1,200,000 | $1,200,000 | 1 | 1 |
| 2019-05-21 | NEPHROS INC | Other Health Care | $2,000,000 | $2,000,000 | 12 | 1 |
| 2018-04-18 | NEPHROS INC | Other Health Care | $2,943,301 | $2,943,301 | 13 | 1 |
| 2017-03-27 | NEPHROS INC | Other Health Care | $2,436,000 | $2,102,615 | 19 | 6 |
| 2015-08-05 | NEPHROS INC | Other Health Care | $10,163,000 | $1,265,000 | 1 | 5 |
| 2015-05-27 | NEPHROS INC | Other Health Care | $1,500,000 | $1,228,982 | 26 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.